Powder: -20°C for 3 years | In solvent: -80°C for 1 year
L-2'-Fd4C is an L-nucleoside analogue with both anti-human immunodeficiency virus (HIV) and anti-hepatitis B virus (HBV) activity [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約10-14 週間 | ¥ 491,500 |
50 mg | 約10-14 週間 | ¥ 639,500 |
100 mg | 約10-14 週間 | ¥ 808,000 |
説明 | L-2'-Fd4C is an L-nucleoside analogue with both anti-human immunodeficiency virus (HIV) and anti-hepatitis B virus (HBV) activity [1]. |
In vitro | L-2'-Fd4C (0-10 μM; 9 d; HepG2-2.2.15 cells) inhibits the replication of hepatitis B virus (HBV) with an EC 50 value of 0.002 μM [1]. |
In vivo | L-2'-Fd4C, administered intraperitoneally at a dosage of 100 mg/kg daily for 7 days, demonstrates significant anti-hepadnaviral activity in HBV-transgenic mice, resulting in a reduction of hepatitis B virus (HBV) levels in the blood comparable to the effects of Lamivudine [1]. |
分子量 | 227.19 |
分子式 | C9H10FN3O3 |
CAS No. | 221662-50-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
L-2'-Fd4C 221662-50-6 Others Inhibitor inhibitor inhibit